{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:25:00Z","timestamp":1786980300050,"version":"build-2736575974"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T00:00:00Z","timestamp":1644883200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T00:00:00Z","timestamp":1644883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>It is plausible that patients with pancreatic cancer experience fear of tumor recurrence or progression (FOP). The aim of this study was to compare FOP in patients with pancreatic cancer treated with surgical resection, palliative systemic treatment, or best supportive care (BSC) and analyze the association between quality of life (QoL) and FOP and the effect of FOP on overall survival (OS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study included patients diagnosed with pancreatic cancer between 2015 and 2018, who participated in the Dutch Pancreatic Cancer Project (PACAP). The association between QoL and WOPS was assessed with logistic regression analyses. OS was evaluated using Kaplan\u2013Meier curves with the log-rank tests and multivariable Cox proportional hazard analyses adjusted for clinical covariates and QoL.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 315 included patients, 111 patients underwent surgical resection, 138 received palliative systemic treatment, and 66 received BSC. Patients who underwent surgical resection had significantly lower WOPS scores (i.e., less FOP) at initial diagnosis compared to patients who received palliative systemic treatment or BSC only (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001). Better QoL was independently associated with the probability of having a low FOP in the BSC (OR 0.95, 95% CI 0.91\u20130.98) but not in the surgical resection (OR 0.97, 95% CI 0.94\u20131.01) and palliative systemic treatment groups (OR 0.97, 95% CI 0.94\u20131.00). The baseline WOPS score was not independently associated with OS in any of the subgroups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Given the distress that FOP evokes, FOP should be explicitly addressed by health care providers when guiding pancreatic cancer patients through their treatment trajectory, especially those receiving palliative treatment or BSC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00520-022-06887-w","type":"journal-article","created":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T15:02:26Z","timestamp":1644937346000},"page":"4879-4887","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The fear of cancer recurrence and progression in patients with pancreatic cancer"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4998-9732","authenticated-orcid":false,"given":"Esther N.","family":"Pijnappel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willemieke P. M.","family":"Dijksterhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam A. G.","family":"Sprangers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Augustinus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"de Vos-Geelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignace H. J. T.","family":"de Hingh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izaak Q.","family":"Molenaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier R.","family":"Busch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc G.","family":"Besselink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna W.","family":"Wilmink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanneke W. M.","family":"van Laarhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Dutch Pancreatic Cancer Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,15]]},"reference":[{"key":"6887_CR1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ejca.2019.11.002","volume":"125","author":"AEJ Latenstein","year":"2020","unstructured":"Latenstein AEJ, van der Geest LGM, Bonsing BA et al (2020) Nationwide trends in incidence, treatment and survival of pancreatic ductal adenocarcinoma. Eur J Cancer 125:83\u201393. https:\/\/doi.org\/10.1016\/j.ejca.2019.11.002","journal-title":"Eur J Cancer"},{"key":"6887_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/978-3-642-40187-9_2","volume":"197","author":"P Herschbach","year":"2014","unstructured":"Herschbach P, Dinkel A (2014) Fear of progression. Recent Results Cancer Res 197:11\u201329. https:\/\/doi.org\/10.1007\/978-3-642-40187-9_2","journal-title":"Recent Results Cancer Res"},{"issue":"11","key":"6887_CR3","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1002\/pon.4880","volume":"27","author":"S Lebel","year":"2018","unstructured":"Lebel S, Maheu C, Tomei C et al (2018) Towards the validation of a new, blended theoretical model of fear of cancer recurrence. Psychooncology 27(11):2594\u20132601. https:\/\/doi.org\/10.1002\/pon.4880","journal-title":"Psychooncology"},{"issue":"2","key":"6887_CR4","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.genhosppsych.2009.11.017","volume":"32","author":"EJ Shim","year":"2010","unstructured":"Shim EJ, Shin YW, Oh DY, Hahm BJ (2010) Increased fear of progression in cancer patients with recurrence. Gen Hosp Psychiatry Mar-Apr 32(2):169\u2013175. https:\/\/doi.org\/10.1016\/j.genhosppsych.2009.11.017","journal-title":"Gen Hosp Psychiatry Mar-Apr"},{"issue":"1","key":"6887_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00520-015-2943-y","volume":"24","author":"DSJ Costa","year":"2016","unstructured":"Costa DSJ, Smith AB, Fardell JE (2016) The sum of all fears: conceptual challenges with measuring fear of cancer recurrence. Support Care Cancer 24(1):1\u20133. https:\/\/doi.org\/10.1007\/s00520-015-2943-y","journal-title":"Support Care Cancer"},{"issue":"4","key":"6887_CR6","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/pon.4103","volume":"26","author":"S Lebel","year":"2017","unstructured":"Lebel S, Ozakinci G, Humphris G et al (2017) Current state and future prospects of research on fear of cancer recurrence. Psychooncol 26(4):424\u2013427. https:\/\/doi.org\/10.1002\/pon.4103","journal-title":"Psychooncol"},{"key":"6887_CR7","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/978-3-319-64310-6_2","volume":"210","author":"A Dinkel","year":"2018","unstructured":"Dinkel A, Herschbach P (2018) Fear of progression in cancer patients and survivors. Recent Results Cancer Res 210:13\u201333. https:\/\/doi.org\/10.1007\/978-3-319-64310-6_2","journal-title":"Recent Results Cancer Res"},{"issue":"4","key":"6887_CR8","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.jpsychores.2012.12.013","volume":"74","author":"J Savard","year":"2013","unstructured":"Savard J, Ivers H (2013) The evolution of fear of cancer recurrence during the cancer care trajectory and its relationship with cancer characteristics. J Psychosom Res 74(4):354\u2013360. https:\/\/doi.org\/10.1016\/j.jpsychores.2012.12.013","journal-title":"J Psychosom Res"},{"issue":"6","key":"6887_CR9","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1002\/pon.1437","volume":"18","author":"T Skaali","year":"2009","unstructured":"Skaali T, Foss\u00e5 SD, Bremnes R et al (2009) Fear of recurrence in long-term testicular cancer survivors. Psychooncol 18(6):580\u2013588. https:\/\/doi.org\/10.1002\/pon.1437","journal-title":"Psychooncol"},{"key":"6887_CR10","doi-asserted-by":"publisher","unstructured":"Nakata H, Halbach S, Geiser F, et al 2020 Health literacy, mental disorders and fear of progression and their association with a need for psycho-oncological care over the course of a breast cancer treatment. Psychol Health Med. 1\u201314. https:\/\/doi.org\/10.1080\/13548506.2020.1772987","DOI":"10.1080\/13548506.2020.1772987"},{"issue":"10","key":"6887_CR11","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1002\/pon.5188","volume":"28","author":"H G\u00f6tze","year":"2019","unstructured":"G\u00f6tze H, Taubenheim S, Dietz A, Lordick F, Mehnert-Theuerkauf A (2019) Fear of cancer recurrence across the survivorship trajectory: results from a survey of adult long-term cancer survivors. Psychooncol 28(10):2033\u20132041. https:\/\/doi.org\/10.1002\/pon.5188","journal-title":"Psychooncol"},{"issue":"4","key":"6887_CR12","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1002\/pon.5010","volume":"28","author":"S Dunne","year":"2019","unstructured":"Dunne S, Coffey L, Sharp L et al (2019) Investigating the impact of self-management behaviours on quality of life and fear of recurrence in head and neck cancer survivors: a population-based survey. Psychooncol 28(4):742\u2013749. https:\/\/doi.org\/10.1002\/pon.5010","journal-title":"Psychooncol"},{"issue":"4","key":"6887_CR13","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1002\/pon.4596","volume":"27","author":"AB Smith","year":"2018","unstructured":"Smith AB, Rutherford C, Butow P et al (2018) A systematic review of quantitative observational studies investigating psychological distress in testicular cancer survivors. Psychooncol 27(4):1129\u20131137. https:\/\/doi.org\/10.1002\/pon.4596","journal-title":"Psychooncol"},{"issue":"5","key":"6887_CR14","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1002\/pon.3114","volume":"22","author":"JV Crist","year":"2013","unstructured":"Crist JV, Grunfeld EA (2013) Factors reported to influence fear of recurrence in cancer patients: a systematic review. Psychooncol 22(5):978\u2013986. https:\/\/doi.org\/10.1002\/pon.3114","journal-title":"Psychooncol"},{"issue":"3","key":"6887_CR15","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/s11764-013-0272-z","volume":"7","author":"S Simard","year":"2013","unstructured":"Simard S, Thewes B, Humphris G et al (2013) Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Surviv 7(3):300\u2013322. https:\/\/doi.org\/10.1007\/s11764-013-0272-z","journal-title":"J Cancer Surviv"},{"issue":"2","key":"6887_CR16","doi-asserted-by":"publisher","first-page":"e216","DOI":"10.1200\/jop.2014.000976","volume":"11","author":"S Moningi","year":"2015","unstructured":"Moningi S, Walker AJ, Hsu CC et al (2015) Correlation of clinical stage and performance status with quality of life in patients seen in a pancreas multidisciplinary clinic. J Oncol Pract 11(2):e216\u2013e221. https:\/\/doi.org\/10.1200\/jop.2014.000976","journal-title":"J Oncol Pract"},{"issue":"6","key":"6887_CR17","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1016\/j.surg.2015.12.024","volume":"159","author":"AP Stark","year":"2016","unstructured":"Stark AP, Sacks GD, Rochefort MM et al (2016) Long-term survival in patients with pancreatic ductal adenocarcinoma. Surgery 159(6):1520\u20131527. https:\/\/doi.org\/10.1016\/j.surg.2015.12.024","journal-title":"Surgery"},{"issue":"2","key":"6887_CR18","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1002\/pon.5265","volume":"29","author":"SJ Kim","year":"2020","unstructured":"Kim SJ, Kang D, Kim IR et al (2020) Impact of fear of cancer recurrence on survival among lymphoma patients. Psychooncol 29(2):364\u2013372. https:\/\/doi.org\/10.1002\/pon.5265","journal-title":"Psychooncol"},{"issue":"5","key":"6887_CR19","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1081\/cnv-200032911","volume":"22","author":"SS Hwang","year":"2004","unstructured":"Hwang SS, Scott CB, Chang VT, Cogswell J, Srinivas S, Kasimis B (2004) Prediction of survival for advanced cancer patients by recursive partitioning analysis: role of Karnofsky performance status, quality of life, and symptom distress. Cancer Invest 22(5):678\u2013687. https:\/\/doi.org\/10.1081\/cnv-200032911","journal-title":"Cancer Invest"},{"issue":"6","key":"6887_CR20","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1177\/0269216320908488","volume":"34","author":"MB Hansen","year":"2020","unstructured":"Hansen MB, Nylandsted LR, Petersen MA, Adsersen M, Rojas-Concha L, Groenvold M (2020) Patient-reported symptoms and problems at admission to specialized palliative care improved survival prediction in 30,969 cancer patients: a nationwide register-based study. Palliat Med 34(6):795\u2013805. https:\/\/doi.org\/10.1177\/0269216320908488","journal-title":"Palliat Med"},{"issue":"2","key":"6887_CR21","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1080\/0284186x.2017.1346381","volume":"57","author":"RRJ van den CoeberghBraak","year":"2018","unstructured":"van den CoeberghBraak RRJ, van Rijssen LB, van Kleef JJ et al (2018) Nationwide comprehensive gastro-intestinal cancer cohorts the 3P initiative. Acta Oncol 57(2):195\u2013202. https:\/\/doi.org\/10.1080\/0284186x.2017.1346381","journal-title":"Acta Oncol"},{"issue":"4","key":"6887_CR22","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1097\/sla.0000000000003779","volume":"271","author":"M Strijker","year":"2020","unstructured":"Strijker M, Mackay TM, Bonsing BA et al (2020) Establishing and coordinating a nationwide multidisciplinary study group: lessons learned by the Dutch Pancreatic Cancer Group. Ann Surg 271(4):e102\u2013e104. https:\/\/doi.org\/10.1097\/sla.0000000000003779","journal-title":"Ann Surg"},{"issue":"9596","key":"6887_CR23","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/s0140-6736(07)61602-x","volume":"370","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370(9596):1453\u20131457. https:\/\/doi.org\/10.1016\/s0140-6736(07)61602-x","journal-title":"Lancet"},{"issue":"1","key":"6887_CR24","doi-asserted-by":"publisher","first-page":"E44","DOI":"10.1097\/NCC.0b013e3182813a17","volume":"37","author":"JA Custers","year":"2014","unstructured":"Custers JA, van den Berg SW, van Laarhoven HW, Bleiker EM, Gielissen MF, Prins JB (2014) The Cancer Worry Scale: detecting fear of recurrence in breast cancer survivors. Cancer Nurs 37(1):E44-50. https:\/\/doi.org\/10.1097\/NCC.0b013e3182813a17","journal-title":"Cancer Nurs"},{"issue":"11","key":"6887_CR25","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1002\/pon.4782","volume":"27","author":"JAE Custers","year":"2018","unstructured":"Custers JAE, Kwakkenbos L, van de Wal M, Prins JB, Thewes B (2018) Re-validation and screening capacity of the 6-item version of the Cancer Worry Scale. Psychooncol 27(11):2609\u20132615. https:\/\/doi.org\/10.1002\/pon.4782","journal-title":"Psychooncol"},{"issue":"3","key":"6887_CR26","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/pon.1570","volume":"19","author":"KF Douma","year":"2010","unstructured":"Douma KF, Aaronson NK, Vasen HF et al (2010) Psychological distress and use of psychosocial support in familial adenomatous polyposis. Psychooncol 19(3):289\u2013298. https:\/\/doi.org\/10.1002\/pon.1570","journal-title":"Psychooncol"},{"issue":"4","key":"6887_CR27","doi-asserted-by":"publisher","first-page":"e722","DOI":"10.1634\/theoncologist.2019-0348","volume":"25","author":"O Husson","year":"2020","unstructured":"Husson O, de Rooij BH, Kieffer J et al (2020) The EORTC QLQ-C30 Summary score as prognostic factor for survival of patients with cancer in the \u201creal-world\u201d: results from the population-based PROFILES registry. Oncologist 25(4):e722\u2013e732. https:\/\/doi.org\/10.1634\/theoncologist.2019-0348","journal-title":"Oncologist"},{"issue":"5","key":"6887_CR28","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"NK Aaronson","year":"1993","unstructured":"Aaronson NK, Ahmedzai S, Bergman B et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365\u2013376. https:\/\/doi.org\/10.1093\/jnci\/85.5.365","journal-title":"J Natl Cancer Inst"},{"key":"6887_CR29","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jclinepi.2015.08.007","volume":"69","author":"JM Giesinger","year":"2016","unstructured":"Giesinger JM, Kieffer JM, Fayers PM et al (2016) Replication and validation of higher order models demonstrated that a summary score for the EORTC QLQ-C30 is robust. J Clin Epidemiol 69:79\u201388. https:\/\/doi.org\/10.1016\/j.jclinepi.2015.08.007","journal-title":"J Clin Epidemiol"},{"issue":"9","key":"6887_CR30","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1007\/s11136-011-0082-6","volume":"21","author":"CM Gundy","year":"2012","unstructured":"Gundy CM, Fayers PM, Groenvold M et al (2012) Comparing higher order models for the EORTC QLQ-C30. Qual Life Res 21(9):1607\u20131617. https:\/\/doi.org\/10.1007\/s11136-011-0082-6","journal-title":"Qual Life Res"},{"key":"6887_CR31","doi-asserted-by":"publisher","unstructured":"Pijnappel EN, Dijksterhuis WPM, van der Geest LG, et al 2021 First- and second-line palliative systemic treatment outcomes in a real-world metastatic pancreatic cancer cohort. J Natl Compr Canc Netw. 1\u20138. https:\/\/doi.org\/10.6004\/jnccn.2021.7028","DOI":"10.6004\/jnccn.2021.7028"},{"issue":"4","key":"6887_CR32","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1002\/pon.3069","volume":"22","author":"N Ghazali","year":"2013","unstructured":"Ghazali N, Cadwallader E, Lowe D, Humphris G, Ozakinci G, Rogers SN (2013) Fear of recurrence among head and neck cancer survivors: longitudinal trends. Psychooncol 22(4):807\u2013813. https:\/\/doi.org\/10.1002\/pon.3069","journal-title":"Psychooncol"},{"issue":"6","key":"6887_CR33","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.jpsychores.2008.03.014","volume":"65","author":"CD Llewellyn","year":"2008","unstructured":"Llewellyn CD, Weinman J, McGurk M, Humphris G (2008) Can we predict which head and neck cancer survivors develop fears of recurrence? J Psychosom Res 65(6):525\u2013532. https:\/\/doi.org\/10.1016\/j.jpsychores.2008.03.014","journal-title":"J Psychosom Res"},{"issue":"5","key":"6887_CR34","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/bjs5.73","volume":"2","author":"AL Young","year":"2018","unstructured":"Young AL, Lee E, Absolom K et al (2018) Expectations of outcomes in patients with colorectal cancer. BJS Open 2(5):285\u2013292. https:\/\/doi.org\/10.1002\/bjs5.73","journal-title":"BJS Open"},{"issue":"5","key":"6887_CR35","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.surg.2013.12.015","volume":"155","author":"J Waljee","year":"2014","unstructured":"Waljee J, McGlinn EP, Sears ED, Chung KC (2014) Patient expectations and patient-reported outcomes in surgery: a systematic review. Surgery 155(5):799\u2013808. https:\/\/doi.org\/10.1016\/j.surg.2013.12.015","journal-title":"Surgery"},{"issue":"9","key":"6887_CR36","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1093\/annonc\/mdt193","volume":"24","author":"J Schildmann","year":"2013","unstructured":"Schildmann J, Ritter P, Salloch S, Uhl W, Vollmann J (2013) \u2018One also needs a bit of trust in the doctor \u2026 \u2019: a qualitative interview study with pancreatic cancer patients about their perceptions and views on information and treatment decision-making. Ann Oncol 24(9):2444\u20132449. https:\/\/doi.org\/10.1093\/annonc\/mdt193","journal-title":"Ann Oncol"},{"issue":"5","key":"6887_CR37","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1080\/0284186x.2018.1563714","volume":"58","author":"LM Wu","year":"2019","unstructured":"Wu LM, McGinty H, Amidi A, Bovbjerg K, Diefenbach MA (2019) Longitudinal dyadic associations of fear of cancer recurrence and the impact of treatment in prostate cancer patients and their spouses. Acta Oncol 58(5):708\u2013714. https:\/\/doi.org\/10.1080\/0284186x.2018.1563714","journal-title":"Acta Oncol"},{"issue":"9","key":"6887_CR38","doi-asserted-by":"publisher","first-page":"3521","DOI":"10.1007\/s00520-019-04665-9","volume":"27","author":"S Goebel","year":"2019","unstructured":"Goebel S, Mehdorn HM (2019) Fear of disease progression in adult ambulatory patients with brain cancer: prevalence and clinical correlates. Support Care Cancer 27(9):3521\u20133529. https:\/\/doi.org\/10.1007\/s00520-019-04665-9","journal-title":"Support Care Cancer"},{"issue":"6","key":"6887_CR39","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.jfma.2019.10.007","volume":"119","author":"YH Lee","year":"2020","unstructured":"Lee YH, Hu CC, Humphris G et al (2020) Screening for fear of cancer recurrence: instrument validation and current status in early stage lung cancer patients. J Formos Med Assoc 119(6):1101\u20131108. https:\/\/doi.org\/10.1016\/j.jfma.2019.10.007","journal-title":"J Formos Med Assoc"},{"issue":"6","key":"6887_CR40","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.tjog.2018.10.014","volume":"57","author":"LY Tsai","year":"2018","unstructured":"Tsai LY, Lee SC, Wang KL, Tsay SL, Tsai JM (2018) A correlation study of fear of cancer recurrence, illness representation, self-regulation, and quality of life among gynecologic cancer survivors in Taiwan. Taiwan J Obstet Gynecol 57(6):846\u2013852. https:\/\/doi.org\/10.1016\/j.tjog.2018.10.014","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"9","key":"6887_CR41","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1002\/pon.4794","volume":"27","author":"S Sanjida","year":"2018","unstructured":"Sanjida S, McPhail SM, Shaw J et al (2018) Are psychological interventions effective on anxiety in cancer patients? A Syst Rev Meta-Analyses Psychooncol 27(9):2063\u20132076. https:\/\/doi.org\/10.1002\/pon.4794","journal-title":"A Syst Rev Meta-Analyses Psychooncol"},{"key":"6887_CR42","doi-asserted-by":"publisher","unstructured":"McConkey RW, Dowling M 2021 Supportive care needs of patients on surveillance and treatment for non-muscle-invasive bladder cancer. Semin Oncol Nurs. 151105. https:\/\/doi.org\/10.1016\/j.soncn.2020.151105","DOI":"10.1016\/j.soncn.2020.151105"},{"issue":"7","key":"6887_CR43","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1002\/pon.5103","volume":"28","author":"I Teo","year":"2019","unstructured":"Teo I, Krishnan A, Lee GL (2019) Psychosocial interventions for advanced cancer patients: a systematic review. Psychooncol 28(7):1394\u20131407. https:\/\/doi.org\/10.1002\/pon.5103","journal-title":"Psychooncol"},{"issue":"6","key":"6887_CR44","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1002\/pon.4735","volume":"27","author":"T Tondorf","year":"2018","unstructured":"Tondorf T, Grossert A, Rothschild SI et al (2018) Focusing on cancer patients\u2019 intentions to use psychooncological support: a longitudinal, mixed-methods study. Psychooncol 27(6):1656\u20131663. https:\/\/doi.org\/10.1002\/pon.4735","journal-title":"Psychooncol"},{"issue":"31","key":"6887_CR45","doi-asserted-by":"publisher","first-page":"9386","DOI":"10.12998\/wjcc.v9.i31.9386","volume":"9","author":"XH Yuan","year":"2021","unstructured":"Yuan XH, Peng J, Hu SW, Yang Y, Bai YJ (2021) Cognitive behavioral therapy on personality characteristics of cancer patients. World J Clin Cases 9(31):9386\u20139394","journal-title":"World J Clin Cases"},{"issue":"3","key":"6887_CR46","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1097\/spc.0000000000000360","volume":"12","author":"NJ Hulbert-Williams","year":"2018","unstructured":"Hulbert-Williams NJ, Beatty L, Dhillon HM (2018) Psychological support for patients with cancer: evidence review and suggestions for future directions. Curr Opin Support Palliat Care 12(3):276\u2013292. https:\/\/doi.org\/10.1097\/spc.0000000000000360","journal-title":"Curr Opin Support Palliat Care"},{"issue":"12","key":"6887_CR47","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1080\/0284186x.2018.1518593","volume":"57","author":"FN van Erning","year":"2018","unstructured":"van Erning FN, Mackay TM, van der Geest LGM et al (2018) Association of the location of pancreatic ductal adenocarcinoma (head, body, tail) with tumor stage, treatment, and survival: a population-based analysis. Acta Oncol 57(12):1655\u20131662. https:\/\/doi.org\/10.1080\/0284186x.2018.1518593","journal-title":"Acta Oncol"},{"issue":"4","key":"6887_CR48","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/ajco.12862","volume":"14","author":"MI Dumbrava","year":"2018","unstructured":"Dumbrava MI, Burmeister EA, Wyld D et al (2018) Chemotherapy in patients with unresected pancreatic cancer in Australia: a population-based study of uptake and survival. Asia Pac J Clin Oncol 14(4):326\u2013336. https:\/\/doi.org\/10.1111\/ajco.12862","journal-title":"Asia Pac J Clin Oncol"},{"issue":"12","key":"6887_CR49","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1002\/ijc.31628","volume":"143","author":"L Huang","year":"2018","unstructured":"Huang L, Jansen L, Balavarca Y et al (2018) Nonsurgical therapies for resected and unresected pancreatic cancer in Europe and USA in 2003\u20132014: a large international population-based study. Int J Cancer 143(12):3227\u20133239. https:\/\/doi.org\/10.1002\/ijc.31628","journal-title":"Int J Cancer"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-022-06887-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-022-06887-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-022-06887-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T06:41:51Z","timestamp":1651041711000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-022-06887-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,15]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["6887"],"URL":"https:\/\/doi.org\/10.1007\/s00520-022-06887-w","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,15]]},"assertion":[{"value":"28 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"According to the Central Committee on Research involving Human Subjects, this type of study does not require approval from an ethics committee in the Netherlands.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JdVG has served as a consultant for Amgen, AstraZeneca, MSD, Pierre Fabre, and Servier and has received institutional research funding from Servier. All outside the submitted work. IHJTdH has received research funding from Roche and RanD Biotech, paid to the institute. JWW has served as a consultant for Shire, Servier, and Celgene and reports grants from Servier, Halozyne, Novartis, Celgene, Astra Zeneca, Pfizer, Roche, and Amgen and Merck. HWMvL reports a consult\/advisory role for BMS, Celgene, Lilly, Merck, Nordic, and Servier and has received unrestricted research funding from Bayer, BMS, Celgene, Lilly, Merck Serono, MSD, Nordic, Philips, Roche, and Servier. The other authors declare that they have no conflicts of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}